Sustainable Development for the Healthcare Industry : Reprogramming the Healthcare Value Chain / edited by Pierre A. Morgon

Gesucht wurde mit: PPN=1654466352;. Treffer: 1

MedienartE-Book [E-Book]
Titel Sustainable Development for the Healthcare Industry : Reprogramming the Healthcare Value Chain / edited by Pierre A. Morgon
PersonMorgon, Pierre A. [Verfasser/in]
VeröffentlichungCham : Springer, 2015
Umfang / Format Online-Ressource (X, 154 p. 14 illus., 8 illus. in color, online resource)
9783319125251 (Druck-Ausgabe)
Nummer1654466352 (SWB-Katalog Nr.)
Weitere AusgabeErscheint auch als Druck-Ausgabe: Sustainable development for the healthcare industry : reprogramming the healthcare value chain / Pierre A. Morgon, ed.. - Cham ; Heidelberg [u.a.], 2015
Schriftenreihe Perspectives on Sustainable Growth
SpringerLink. Bücher
Springer eBook Collection. Business and Economics
Schlagwörter Economics
Sustainable development
Economics/Management Science
Schlagwortfolge Gesundheitsökonomie ; Nachhaltigkeit ; Wertschöpfungskette
Systematik QX 705 Gesundheitspolitik
Inhalt This volume addresses the dynamics of sustainable development in the healthcare industry, covering all major aspects of the industry, including R&D, manufacturing, regulation, market access, commercialization, and general management.  Healthcare markets are evolving under demographic and economic pressures. In mature markets, patients navigate highly complex provider and cash-strapped payer systems with limited control on healthcare quality and outcomes (as reflected by the absence of correlation between spending and patient satisfaction and outcomes). In developing markets, patients have limited awareness, access and ability to pay for healthcare. The pools of profit will progressively shift from prescription drugs to other product segments and to healthcare delivery, and these shifts will be different by region. As it is dealing with a R&D drought, a revenues deflation induced by patient expiries affecting primary care franchises, a portfolio mix evolution towards specialty care products designed for highly profiled patient populations and backed by complex scientific and medical data, the industry needs to identify which business targets are genuinely attractive for major or new investments.   At the same time, development of new products and services must be tackled within the context of environmental sustainability.  Rather than focusing on the traditional issues of innovation, cost management, and commercial effectiveness associated with growth, the authors-including leading academics and industry insiders-explore such emerging topics as: The mutations of the management of innovation, as it remains the DNA of the healthcare industry, driven by patient focus and the trend towards personalized medicine the need to foster patient-centricity along the entire value chain of the healthcare industry and company-wide, starting by listening to the voice of the patient earlier in the lifecycle of drug candidates the broad scope of issues related to improving access to care and disease management, from drug design, to innovative licensing, to valuation based on real-world evidence, to supply and availability so as to ensure optimal access the allocation of educational resources focused on the patient to increase the effectiveness of disease management the preservation of natural resources and the environmental effects of pollution and hazards created by the handling of pharmaceutical products the capacity issues in relation to the size of the medical need an ...
Bitte klicken Sie für den Volltext-Zugriff auf den Link


Weitere Infos

ZugangURLHinweis zur URL
E-BOOK: Link zum Volltext - nur auf dem Campus verfügbar http://dx.doi.org/10.1007/978-3-319-12526-8 Zugriff von allen im Hochschulnetz befindlichen Rechnern; Hochschulangehörige können auch über VPN von außerhalb des Campusnetzes zugreifen